Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin in Pre-diabetic Subjects with Impaired Fasting Glucose
NCT00312130Phase 3Completed
- Sponsor
- Novartis
- Start
- Apr 2005
- Primary completion
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vildagliptin in prediabetes, sponsored by Novartis. Started Apr 2005; status: completed.
02
Drugs
vildagliptin
03
Conditions
prediabetes
Beyond the preview
Go deeper on NCT00312130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00312130.